[ad_1]
NEW YORK, July 6, 2022 /PRNewswire/ — The “Foot and Mouth Disease Vaccines Market by Product and Geography – Forecast and Analysis 2021-2025” report by Technavio expects the market size to increase by USD 1.08 billion between 2020 and 2025. The market observed a YOY growth of 8.50% and the growth momentum is expected to accelerate at a CAGR of 8.81% during the forecast period. According to the report, the Asian market will generate huge growth opportunities for vendors. The widespread awareness programs are undertaken by governments and the implementation of needle and syringe exchange programs in Australia, New Zealandand Malaysia are driving the demand for foot and mouth disease vaccines in the region.
Get more insights into the current market scenario, future growth opportunities, and other important statistics. Read Our Sample Report Now
Market Dynamics
The market is mainly driven by the increase in government initiatives. Governments across the world are undertaking various initiatives to eradicate FMD. For instance, the US Congress passed a Farm Bill in December 2018 to provide funding for an animal vaccine bank emphasizing the development of FMD vaccines. Similarly, in Indiathe Prayagraj animal husbandry department in Uttar Pradesh state launched a massive drive to treat cows and other cattle from the deadly foot and mouth disease. Such initiatives are creating a high demand for FMD vaccines across the globe.
In addition, frequent foot and mouth disease (FMD) outbreaks in Asia and the Middle East and the increase in demand for livestock products will have a positive impact on the growth of the market. However, the increase in vaccine failures is expected to hinder the growth of the market.
Competitive Analysis
Some of the companies covered in this report are Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Indian Immunologicals Ltd., Inovio Pharmaceuticals Inc., LIMOR DE COLOMBIA SA, Merck & Co. Inc., SEPPIC SA, VECOL SA, and VETAL Animal Health Products Inc., etc. The competitive scenario provided in the foot and mouth disease vaccines market report analyzes, evaluates, and positions companies based on various performance indicators . Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.
The market is concentrated. Vendors in the market are focusing on implementing new technologies and new product offerings. They are adopting various strategies to increase their market shares and remain competitive in the market. Some of the major strategies adopted by them include product launches, M&A , distribution through partnerships, participation in medical trade shows, and product development through the use of advanced technologies.
View Sample Report to gain more insights into the market dynamics and the vendor landscape.
Market Segmentation by Product:
- By product, the market is classified into conventional vaccines and emergency vaccines.
- The market growth in the conventional vaccines segment will be significant during the forecast period.
- The segment is driven by the presence of FMD endemic in various countries such as India, China, Bangladesh, South Korea, Pakistanand Hong Kong.
Market Segmentation by Product:
- By geography, the market is classified as Asia, Europe, North Americaand ROW.
- Asia will have the largest share of the market.
- The presence of a…
Full story available on Benzinga.com
[ad_2]
Source link
